June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Thor Halfdanarson: Radiosensitivity of NET in Locally Advanced G2 Pancreatic Tumor Treated with CAPTEM and CRT
Jan 30, 2025, 17:27

Thor Halfdanarson: Radiosensitivity of NET in Locally Advanced G2 Pancreatic Tumor Treated with CAPTEM and CRT

Thor Halfdanarson, Vice President of the North American Neuroendocrine Tumor Society, shared on X:

“A reminder that NETs are radiosensitive tumors. Locally advanced, nonmetastatic, unresectable (extensive vascular involvement, cavernous portal vein transformation) G2 panc NET (Ki67 9%). CAPTEM x12 with good partial response, followed by CRT with capecitabine. 23 months post CRT.”

Thor Halfdanarson: Radiosensitivity of NET in Locally Advanced G2 Pancreatic Tumor Treated with CAPTEM and CRT

More posts featuring Thor Halfdanarson.